Watch: She had a home and a good-paying job. Then illness and debt upended it all.

Sharon Woodward used to travel the country as a medical technician. She made good money and prided herself on her skills.

UK’s NICE recommends AbbVie’s Aquipta to treat migraines – Pharmaceutical Technology

Share this article According to GlobalData, the migraine drugs market is set to be worth $18.6bn in 2030 globally. Credit: Krakenimages.com via Shutterstock. The National

April 11, 2024

New guidance balances GLP-1 risks and benefits for surgery

Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective surgery and gastrointestinal endoscopies, according to new clinical

October 30, 2024

Sun, surprises and new summits at Europe’s biggest cancer conference

BARCELONA — More than 33,000 oncologists, medical researchers, biopharma leaders and other delegates attended Europe’s largest cancer meeting over the past few days in Spain

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.